We are pleased to announce the winners of the Antibiotics 2021 Best Paper Awards. All papers published in 2019 in Antibiotics were considered for the award. After a thorough evaluation of the originality and significance of the papers, citations, and downloads, the two winning papers, which were nominated by the journal Award Committee, have been selected.

Antimicrobial and Synergistic Effects of Commercial Piperine and Piperlongumine in Combination with Conventional Antimicrobials
By Eunice Ego Mgbeahuruike, Milla Stålnacke, Heikki Vuorela and Yvonne Holm
Antibiotics 2019, 8(2), 55

Antibiotic Discovery: Where Have We Come from, Where Do We Go?
By Bernardo Ribeiro da Cunha, Luís P. Fonseca and Cecília R. C. Calado
Antibiotics 2019, 8(2), 45

Each winner will receive 500 CHF and the opportunity to publish one paper with 50% discount in Antibiotics in 2021. We believe the above papers represent valuable contributions to Antibiotics and the scientific literature. We warmly congratulate the winners.

Kind regards,
Antibiotics Editorial Office

Dear Colleagues,

The journal Antibiotics (MDPI, Switzerland, IF 3.893, ISSN 2079-6382, https://0-www-mdpi-com.brum.beds.ac.uk/journal/antibiotics) is inviting applications for the Antibiotics 2021 Ph.D. Thesis Award. This prize will be awarded to a Ph.D. student who is about to graduate or participate in the graduation thesis. The applications will be assessed by an Evaluation Committee consisting of senior scholars from the Antibiotics Editorial Board.

Eligibility Requirements:

a. The candidate must be a Ph.D. student who is going to graduate or participate in graduation thesis defenses.
b. The Ph.D. thesis must be original work.
c. The Ph.D. thesis must be defended between 1 January 2021 and 31 December 2021.
d. Applicants are required to submit the following documents:
  – An executive summary of the Ph.D. thesis in English, of around 3000 words;
  – A letter from Ph.D. supervisor recommending the candidate for consideration for this award;
  – The candidate’s CV, including a list of publications connected with the thesis;
  – An electronic copy of the Ph.D. thesis;
  – A scanned copy of the Ph.D. diploma (or certificate of studying at a school or research institute as a Ph.D. student going to graduate or participate in graduation thesis defenses).

Selection Criteria:

– Quality of resume and publications;
– Relevance of the candidate and research description;
– Novelty of the candidate’s Ph.D. thesis;
– Strength of the recommendation letter;
– Anticipated academic potential;
– Originality and impact of the research.

Prizes:

– Bonus (1000 CHF);
– Certificate;
– Offer to publish a featured paper in Antibiotics with the article processing charge (APC) waived before the end of 2022.

How to apply?

– Please submit your application online.

The application deadline is 15, January 2022. The winner will be announced on the Antibiotics website by the end of March 2022.

Please feel free to contact us at [email protected] with any questions.

Dear Colleagues,

We are pleased to announce the winners of the Antibiotics 2020 Outstanding Reviewer Award. The Antibiotics Editorial Board and Editorial Team would like to gratefully acknowledge the time and energy dedicated by reviewers in checking the manuscripts submitted to Antibiotics. It is due to their efforts that the high quality of the journal and quick turnaround is maintained.

Jean Vanderpas
Consultant Ecole Santé Publique, Université Libre de Bruxelles, Bruxelles, Belgium
Research Interest: Infectious Disease Surveillance; Epidemiological Analysis; Clinical Epidemiology; Epidemiological Statistics; Infectious Disease Epidemiology; Selenium; Vaccines; Metabolites; Rabies Vaccines

Morgan Feeney
Strathclyde Institute Of Pharmacy And Biomedical Sciences, University of Strathclyde, Glasgow, UK
Research Interest: oxidative stress; antibiotics; Streptomyces; bacterial genetics; suppressor analysis

Kind regards,
Antibiotics Editorial Office

Dear Colleagues,

We are pleased to announce that the winner of the Antibiotics 2020 Young Investigator Award is Dr. Cesar de la Fuente.

Dr. Cesar de la Fuente is the Presidential Assistant Professor at the University of Pennsylvania. He is a leader of his generation of computational and synthetic biologists pushing the frontiers of antibiotic discovery. His out-of-the-box work is having a profound impact on the design and synthesis of antimicrobial medicines and on the field of infectious diseases as a whole. Dr. Cesar de la Fuente received his PhD in 2014 and has an outstanding publication record, comprising 91 publications in peer-reviewed international journals and over 10 international patents. His Scopus Scientific Citations number is 4600, and his Hirsch index is 31. He is clearly a rising star in the field of antibiotic discovery, microbiology, synthetic biology, computational biology, and infectious diseases. He has received substantial funding for his independent work and is also an active and leading entrepreneur, and some of his patents involving the use of synthetic peptides for the treatment of infectious diseases have been licensed to a number of companies and are currently under development. Please join us in congratulating Dr. Cesar de la Fuente for his outstanding achievements.

As the awardee, Dr. Cesar de la Fuente will receive an honorarium of CHF 2000, an offer to publish a paper free of charge before the end of December 2021 in Antibiotics after peer review, and an engraved plaque.

We would like to thank all the nominators from various fields of study for their participation and all the Award Committee Members for their evaluation of the many excellent nominations.

Antibiotics 2020 Young Investigator Evaluation Committee

Dear Colleagues,

As the Chair of the Travel Awards Evaluation Committee, I am pleased to announce the winner of the 2019 Antibiotics Travel Award.

The Evaluation Committee were very impressed with the high level of work presented, and after careful consideration, the Travel Award have been granted to Mr. Damien Cabral, a Ph.D. student at Brown University, Providence, RI, USA, who is working on characterizing the functional response of the gut microbiome to antibiotic therapy.

The winner will receive 800 Swiss Francs to be used to attend and participate at any academic conference in 2019.

It is also our pleasure to announce that as part of the reward, Antibiotics will offer the Top 10 candidates the opportunity to publish a paper with the publication fees waived. We would like to thank all applicants for their participation and interest in our journal.

We also thank our Evaluation Committee members, Drs. Gary A. Strobel, Patrice Courvalin and William M. Shafer, for their comprehensive evaluation of the candidates.

Prof. Dr. Jeffrey Lipman
Chair of the Evaluation Committee

Dear Colleagues,

As Editor-in-Chief of Antibiotics, I am pleased to announce the winners of the 2017 Antibiotics Travel Awards. The Evaluation Committee were very impressed with the high level of work presented and, after careful consideration, the two Travel Awards have been granted to Dr. Bimal Jana, a postdoctoral fellow at Ross University, Basseterre, St. Kitts, for his work on identifying chromosomal non-essential genes that are essential for MDR Klebsiella pneumoniae ST258 under the presence of therapeutically relevant concentrations of antimicrobial; and to Vera Pader, a Ph.D. student at Imperial College London, London, UK, working on the link between antibiotic resistance and virulence in Staphylococcus aureus.

The awards consist of 800 Swiss Francs each, and are available for the winners to use for attendance and participation in any academic conferences in 2017.

It is also our pleasure to announce that as part of the reward, Antibiotics will offer the Top 35 candidates the opportunity to publish a paper with the publication fees waived. We would like to thank all applicants for their participation and interest in our journal.

We would also like to deliver our great thanks to the Evaluation Committee members, Drs. Andrei L. Gartel, Gary A. Strobel, Gian Maria Rossolini, Jeffrey Lipman, Leonard Amaral, Morten Lindbæk, Nora Vazquez-Laslop, Patrice Courvalin, William M. Shafer and Ying Zhang, for their comprehensive evaluation of candidates.

Prof. Dr. Christopher C. Butler
Editor-in-Chief